A Granulomatous Drug Eruption Induced by Entecavir
Annals of Dermatology
;
: 493-495, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-123640
ABSTRACT
Entecavir (Baraclude(R), Bristol-Myers Squibb) is a potent and selective antiviral agent that has demonstrated efficacy in patients with chronic hepatitis B. The most frequent adverse events attributed to entecavir include increased alanine aminotransferase, upper respiratory tract infection, headache, abdominal pain, cough, pyrexia, fatigue, and diarrhea. Although quite a few randomized double-blind studies including ones investigating adverse events along with these general symptoms have been reported, few cases of cutaneous adverse events have been described in detail. We demonstrate a case of granulomatous drug eruption as a cutaneous adverse event induced by entecavir.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Infecciones del Sistema Respiratorio
/
Dolor Abdominal
/
Método Doble Ciego
/
Erupciones por Medicamentos
/
Hepatitis B Crónica
/
Tos
/
Diarrea
/
Alanina Transaminasa
/
Fatiga
/
Fiebre
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Humanos
Idioma:
Inglés
Revista:
Annals of Dermatology
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS